European Research Council earmarks funding to explore commercial potential of research work
The European Research Council (ERC) has awarded its ERC Proof of Concept grant to Ikerbasque researcher Asís Palazón, leader of the Immuno-Oncology laboratory at CIC bioGUNE – a member of the Basque Research & Technology Alliance, BRTA.
ERC Proof of Concept projects funded by the European Research Council (ERC) are aimed at researchers who currently hold ERC projects and who want to explore the commercial potential of their research work. These projects are aimed at establishing proof of concept of an idea that was generated in the course of ERC-funded projects. The funding of ¤150,000 is primarily for activities aimed at converting research results into a commercial product.
Specifically, the project supported on this occasion by the ERC emerges from the research carried out in the framework of the “Next Generation Immuno-Oncology” (NextGen_IO) project being developed at CIC bioGUNE. The aim of the project is to study the feasibility of creating a new company in the Basque Country, focused on the development of new immunotherapies. Specifically, the current focus is on the development of new inhibitor compounds and cell therapies with T cells (CAR-T) in the preclinical phase, with a view to reaching clinical phases in the coming years.